✦ LIBER ✦

Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists

✍ Scribed by Goleva, Elena; Dunlap, Annegret; Leung, Donald Y.M.

Book ID: 119274468
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 416 KB
Volume: 114
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2004.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regarding “Differential control of TH1 v

Regarding “Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists”

✍ Friesen, Jason H.C.; Ameredes, Bill T.; Calhoun, William J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Control of T-cell responses by the combi

Control of T-cell responses by the combination of low dose steroids with beta2-agonists*1

✍ DUNLAP, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Effects of β2-agonist on the Productions

Effects of β2-agonist on the Productions of Th1 and Th2 cytokines by Mononuclear Cells from patients with asthma

✍ Yamaguchi, T.; Takaku, Y.; Nakagome, K.; Soma, T.; Hagiwara, K.; Kanazawa, M.; N 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Therapeutic effect of low-dose IL-18 com

Therapeutic effect of low-dose IL-18 combined with IL-10 on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of Th2 responses

✍ Qiaomei Dai; Yang Li; Fengshan Zhang; Haiyue Yu; Xiaoyan Wang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 515 KB

The mouse chorionic gonadotropin β-subun

The mouse chorionic gonadotropin β-subunit-like (muCGβl) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CGβ (rmCGβ)

✍ Shu-Qun Shi; Jing-Pian Peng; Li Xu; Ying Yang; Yun Chen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 1 views

## Abstract ## Background CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno‐therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T‐cell responses and humoral responses